Involvement of the endocannabinoid system in periodontal healing

Biochemical and Biophysical Research Communications

Volumn 394, Issue 4, 2010, Pages 928-933

  Kozono, Sayaka ^a   Matsuyama, Takashi ^a   Biwasa, Kamal Krishna ^b   Kawahara, Ko ichi ^a   Nakajima, Yumiko ^a   Yoshimoto, Takehiko ^a   Yonamine, Yutaka ^a   Kadomatsu, Hideshi ^a   Tancharoen, Salunya ^c   Hashiguchi, Teruto ^a   Noguchi, Kazuyuki ^a   Maruyama, Ikuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF RAJSHAHI   (Bangladesh)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Cannabinoid receptors; Endocannabinoids; Gingival fibroblasts; Mitogen activated protein kinases; Proliferation; Wound healing

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; ENDOCANNABINOID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FIBROBLAST; GINGIVA; GRANULATION TISSUE; HEALING; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; NONHUMAN; PERIODONTAL DISEASE; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; WOUND CLOSURE; WOUND HEALING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ARACHIDONIC ACIDS; CELL PROLIFERATION; ENDOCANNABINOIDS; FIBROBLASTS; GINGIVAL CREVICULAR FLUID; GLYCERIDES; HUMANS; INDOLES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERIODONTIUM; PHOSPHORYLATION; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RATS; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; WOUND HEALING;

MAMMALIA; RATTUS;

EID: 77950862353     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.03.080     Document Type: Article

References (31)

1. Singer A.J., and Clark R.A. Cutaneous wound healing. N. Engl. J. Med. 341 (1999) 738-746
2. Martin P. Wound healing-aiming for perfect skin regeneration. Science 276 (1997) 75-81
3. Kupczyk P., Reich A., and Szepietowski J.C. Cannabinoid system in the skin - a possible target for future therapies in dermatology. Exp. Dermatol. 18 (2009) 669-679
4. Mallat A., and Lotersztajn S. Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver. Am. J. Physiol. Gastrointest. Liver Physiol. 294 (2008) G9-G12
5. Garcia-Ovejero D., Arevalo-Martin A., Petrosino S., Docagne F., Hagen C., Bisogno T., Watanabe M., Guaza C., Di Marzo V., and Molina-Holgado E. The endocannabinoid system is modulated in response to spinal cord injury in rats. Neurobiol. Dis. 33 (2009) 57-71
6. Izzo A.A., and Camilleri M. Cannabinoids in intestinal inflammation and cancer. Pharmacol. Res. 60 (2009) 117-125
7. Kim J., and Amar S. Periodontal disease and systemic conditions: a bidirectional relationship. Odontology 94 (2006) 10-21
8. Polimeni G., Xiropaidis A.V., and Wikesjo U.M. Biology and principles of periodontal wound healing/regeneration. Periodontology 2000 41 (2006) 30-47
9. Nakajima Y., Furuichi Y., Biswas K.K., Hashiguchi T., Kawahara K., Yamaji K., Uchimura T., Izumi Y., and Maruyama I. Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition. FEBS Lett. 580 (2006) 613-619
10. Wang Y., Liu Y., Sarker K.P., Nakashima M., Serizawa T., Kishida A., Akashi M., Nakata M., Kitajima I., and Maruyama I. Polymyxin B binds to anandamide and inhibits its cytotoxic effect. FEBS Lett. 470 (2000) 151-155
11. Wang Y., Liu Y., Ito Y., Hashiguchi T., Kitajima I., Yamakuchi M., Shimizu H., Matsuo S., Imaizumi H., and Maruyama I. Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock. Anal. Biochem. 294 (2001) 73-82
12. Goldberg S.R., Quirk G.L., Sykes V.W., McKinstry R.P., Kordula T., and Lanning D.A. Differential use of Erk1/2 and transforming growth factor beta pathways by mid- and late-gestational murine fibroblasts. J. Pediatr. Surg. 43 (2008) 971-976
13. Embery G., and Waddington R. Gingival crevicular fluid: biomarkers of periodontal tissue activity. Adv. Dent. Res. 8 (1994) 329-336
14. Wright K., Rooney N., Feeney M., Tate J., Robertson D., Welham M., and Ward S. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology 129 (2005) 437-453
15. Defer N., Wan J., Souktani R., Escoubet B., Perier M., Caramelle P., Manin S., Deveaux V., Bourin M.C., Zimmer A., Lotersztajn S., Pecker F., and Pavoine C. The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy. FASEB J. 23 (2009) 2120-2130
16. Freund T.F., Katona I., and Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83 (2003) 1017-1066
17. Klein T.W., Newton C., Larsen K., Lu L., Perkins I., Nong L., and Friedman H. The cannabinoid system and immune modulation. J. Leukoc. Biol. 74 (2003) 486-496
18. Palazuelos J., Aguado T., Egia A., Mechoulam R., Guzman M., and Galve-Roperh I. Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation. FASEB J. 20 (2006) 2405-2407
19. Wilkinson J.D., and Williamson E.M. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis. J. Dermatol. Sci. 45 (2007) 87-92
20. Rajesh M., Mukhopadhyay P., Hasko G., and Pacher P. Cannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferation. Biochem. Biophys. Res. Commun. 377 (2008) 1248-1252
21. Trazzi S., Steger M., Mitrugno V.M., Bartesaghi R., and Ciani E. CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT/GSK-3{beta}/{beta}-catenin signaling. J. Biol. Chem. 285 (2010) 10098-10109
22. Julien B., Grenard P., Teixeira-Clerc F., Van Nhieu J.T., Li L., Karsak M., Zimmer A., Mallat A., and Lotersztajn S. Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology 128 (2005) 742-755
23. Teixeira-Clerc F., Julien B., Grenard P., Tran Van Nhieu J., Deveaux V., Li L., Serriere-Lanneau V., Ledent C., Mallat A., and Lotersztajn S. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat. Med. 12 (2006) 671-676
24. Bab I., Ofek O., Tam J., Rehnelt J., and Zimmer A. Endocannabinoids and the regulation of bone metabolism. J. Neuroendocrinol. 20 Suppl. 1 (2008) 69-74
25. Kogan N.M. Cannabinoids and cancer. Mini Rev. Med. Chem. 5 (2005) 941-952
26. Molina-Holgado F., Rubio-Araiz A., Garcia-Ovejero D., Williams R.J., Moore J.D., Arevalo-Martin A., Gomez-Torres O., and Molina-Holgado E. CB2 cannabinoid receptors promote mouse neural stem cell proliferation. Eur. J. Neurosci. 25 (2007) 629-634
27. S.A. Rieder, A. Chauhan, U. Singh, M. Nagarkatti, P. Nagarkatti, Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression, Immunobiology (2010), in press.
28. Pacher P., Batkai S., and Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 58 (2006) 389-462
29. Basavarajappa B.S. Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity. Curr. Neuropharmacol. 5 (2007) 81-97
30. Ranzato E., Patrone M., Mazzucco L., and Burlando B. Platelet lysate stimulates wound repair of HaCaT keratinocytes. Br. J. Dermatol. 159 (2008) 537-545
31. Montecucco F., Burger F., Mach F., and Steffens S. CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways. Am. J. Physiol. Heart Circ. Physiol. 294 (2008) H1145-H1155